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Abstract. Monoclonal antibodies are assuming increasing 
importance in experimental and clinical medicine. General- 
ly, tissue biodistribution studies in animals precede human 
studies. To investigate a concern of ours that varying meth- 
ods of sample handling in these studies could result in ap- 
parent alterations in tissue-binding levels, we compared two 
methods of tissue processing after the administration of 
labeled antibodies: one including only blotting away of 
blood, the other involving several washing steps. The un- 
washed, blotted specimens were found to have significantly 
more radioactivity per gram of tissue than the washed, 
ranging from 22% more in the spleen to 52% more in 
the lungs and left ventricle. Since in vivo imaging is depen- 
dent on the total mount of radioactivity in an organ, we 
believe the most meaningful determination of tissue radio- 
activity should be based on unwashed samples. Awareness 
of  this problem is suggested to allow meaningful extrapola- 
tions from measured tisue localization data to imaging and 
therapy. 
Radiolabeled monoclonal antibodies hold great promise as 
specific imaging agents in nuclear medicine and as carriers 
of therapeutic radionuclides to tumors. Many laboratory 
studies are ongoing in animal model systems, evaluating 
the degree of labeled antibody localization. In many of these 
studies, relatively high levels of blood pool activity are pres- 
ent, especially at early time points after administration of 
the intact labeled antibody (Ballou et al. 1979; Wahl et al. 
1983). Although the use of F (ab')2 fragments has decreased 
this problem somewhat, moderate blood levels are still be- 
ing seen (Wahl et al. 1983b). This problem has been ap- 
proached in clinical imaging by background subtraction 
methods (Goldenberg et al. 1978; Mach et al. 1981). In lab- 
oratory animals, however, this problem of high blood-back- 
ground levels seemed a potential source of confusion in 
interpreting laboratory data. 
Since labeled antibodies, at relatively early time points 
after injection are both in the blood-stream and in the target 
tissues, it seemed that the apparent radioactivity in the tis- 
sue would be dependent on how much blood pool activity 
was removed in sample processing. A variety of approaches 
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to sample processing have been described in the literature 
including: exhaustively perfusing the experimental animals 
with saline to remove all blood (Koji et al. 1980); mincing 
and homogenizing the tissue and washing repeatedly, blend- 
ing and weighing the wet specimen (Bernhard et al. 1983), 
washing tissues several times in phosphate-buffered saline 
" to  get rid of as much blood as possible" (Ghose et al. 
1975); lightly blotting surface blood from the target tissues, 
weighing and counting them with contained blood present 
(Wahl and Parker 1983c); carefully removing the tissue, 
weighing and counting (Hoffer et al. 1973); and not clearly 
specified which we assume to mean simple excision and 
counting (Primus et al. 1973). 
The lack of uniformity in the literature in sample pro- 
cessing is not surprising; however, we were concerned that 
these different methods might give different results for the 
same radiopharmaceutical. To evaluate the importance of 
this potential problem on localization studies, we elected 
to investigate the behavior of a radiolabeled non-specific 
monoclonal antibody using two different modes of sample 
processing, one preserving blood content, the other deplet- 
ing to some extent blood content, through repeated wash- 
ings. 
Methods 
UPC-10 mouse myeloma protein (IgG-2a kappa) of no 
known tissue specificity was purchased from Litton bionet- 
its as a purified product. This was radiolabeled with 125I 
using a modification of the method of Hunter and Gren- 
wood (Greenwood et al. 1963); 100 ~tg was labeled to an 
activity of 70 Ci. This was passed over a biorad P-60 gel 
exclusion-column to separate free from bound 125I. Anti- 
body purity was confirmed on SDS polyacrylamide gel elec- 
trophoresis using a 7.7% gel. Five normal female Sprague 
Dawley rats (Harlan-Sprague Dawley, Indianapolis, IN) 
were injected with 15 Ci of 125I UPC-10 (approximately 
20 gg) via a femoral vein cut-down. Animals were killed 
24 h after injection, immediately after blood samples were 
obtained. 
Four similar-sized aliquots from the liver, kidney, lung, 
spleen, and left ventricle were removed. Tissues obtained 
from each animal were immediately blotted to remove ex- 
cessive blood, then either weighed or washed in phosphate- 
buffered saline solution. The tissue aliquots for washing 
were washed in serial petri dishes with saline, incised in 
several locations, washed two more times, blotted, and 
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Table 1. Percentage of injected dose per kilogram per gram of tissue 
with and without washing 
Washed Unwashed % Difference 
Liver 0.0523 + 0.003 0.0689 + 0.002 32% * 
Kidney 0.0589_+0.006 0.083 +0.005 40%* 
Spleen 0.0638 _ 0.005 0.078 _+ 0.004 22% * 
Left ventricle 0.0633_+0.005 0.097 -+0.003 52%* 
Lung 0.133 +_0.022 0.202 +_0.011 52%* 
Blood 0.403 +_0.018 0% 
Mean of 10 specimens + SEM. 
* P =  <0.0001 
Table 2. Rank order of tissue radioactivity per gram before and 
after washing 
Unwashed : 
Blood > lung > left ventricle > kidney > spleen > liver 
Washed : 
Blood > lung > spleen > left ventricle > kidney > liver 
weighed. Tissues processed by blotting once or by three 
washings were counted at the 125I channel in a gamma 
counter. After correction for physical decay, the percentage 
of  the injected dose per gram of  tissue was calculated (with 
normalization to a 1000-g animal), i.e., % kg dose/g. Thus 
each animal and tissue served as its own control for the 
two different sample processing methods. Differences be- 
tween means were calculated using the paired two-column 
t-test. 
Results 
As illustrated in Table 1, there are significant differences 
between the blotted only and the blotted and washed tissues 
radioactivity (p < 0.0001). These differences are least strik- 
ing for the spleen with a 22% change and most  striking 
for the left ventricle and the lungs (with the blotted only 
specimens having 52% more activity than the washed speci- 
mens). The unwashed tissue from the vascular spleen, liver, 
and kidneys are 22%, 32% and 40% greater in activity 
per gram than the comparable washed tissues. Blood pool 
activity is relatively high at twice lung activity at this early 
time point. In addition, the relative amount  of  radioactivity 
among the tissues studied varied with and without washing 
(Table 2). 
Discussion 
These data show that marked differences can occur in the 
apparent tissue distribution of  labeled antibodies simply 
due to minor alterations in sample processing after sacrifice. 
Although this phenomenon has been shown with radiola- 
beled serum albumin and exhaustive perfusion of  animals 
with saline (Bauer et al. 1955), we were surprised at the 
magnitude of  the changes we saw. While initially expecting 
only the relative amounts of  radioactivity in the tissues 
which were washed to drop, it was noted that the drops 
were variable and, as is shown in Table 2, the relative 
amounts of  radioactivity per gram of  tissue varied, so that 
spleen is higher relative to other washed tissues after wash- 
ing than it was prior to washing. As would be expected, 
the left ventricle drops in activity both absolutely and rela- 
tively compared to the other tissues with washing, presum- 
ably largely due to washing away of  blood pool activity. 
These changes after washing would likely be much 
smaller if less of  the radioactivity was initially present in 
the blood pool, as is the case with many other radiopharma- 
ceuticals and with antibodies that localize very well. These 
changes in absolute and relative tissue radioactivity content, 
with simple modifications in processing, are also sur- 
prisingly large, particularly because we did not attempt ex- 
haustively to remove all contained blood. 
Although no tissue to which the antibody was specifi- 
cally directed was studied, it is probable that such a tissue 
would retain radioactivity better than one in which much 
of  the radiolabeled antibody was loosely bound. If  this were 
the case, then tumor to background ratios could be artifac- 
tually inflated (though not tumor/blood ratios). Further 
work on this question is necessary. 
Although it is intellectually appealing to know how 
much radioactivity is in the liver without the surrounding 
blood's  contribution, it seems to us that what is important  
in nuclear imaging, and possibly therapy, is the total radio- 
activity in the organ (including that due to the blood pool 
activity) relative to background, rather than that radioactiv- 
ity which is not  easily washed away from the organ. When 
nuclear images are obtained using radiolabeled antibodies, 
the organs are not washed free of  blood, and background 
subtraction of  this blood activity has been necessary in 
many studies (Mach et al. 198t). For  these reasons, we feel 
it may be more meaningful in attempts to extrapolate ani- 
mal tissue distribution work with labeled antibodies to hu- 
man imaging studies, to report tissue radioactivity accumu- 
lation data with a specimen processing method including 
blotting only for excess surface blood. Care should be taken 
not to include extensive washings which, as demonstrated 
here, remove much radioactivity, probably largely situated 
in the washed organ's  blood pool. 
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